Study of HS-10582 for mildly elevated LDL cholesterol
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called HS-10582 to see if it is safe and how well it works in people with mildly high LDL cholesterol (the 'bad' cholesterol). It may help lower cholesterol levels and could be a future treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- Your body mass index (BMI) is between 19 and 32
- You weigh at least 50 kg (110 lbs) if you are a man, or 45 kg (99 lbs) if you are a woman
- You are generally healthy, with no significant medical conditions
- You are not pregnant or breastfeeding
- You have not taken any medications (including over-the-counter, herbal, or supplements) within 2 weeks before the study starts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.